The antiviral drug, Remdesivir, which was used during Ebola outbreak may be highly effective in stopping the replication mechanism of SARS-CoV-2 that causes Covid-19, the Indian Council of Medical Research said on Monday.
The ICMR said research on its efficacy in the treatment of Covid-19 is a part of WHO's "Solidarity Trial".
The ICMR said research on its efficacy in the treatment of Covid-19 is a part of WHO's "Solidarity Trial".
According to a recently published study in the New England Journal of Medicine, two out of three critically ill coronavirus infected patients who were on oxygen support or on ventilators showed signs of improvement when they were administered remdesivir.
Commenting on the study, Head of Epidemiology and Communicable

)